SARS-CoV-2 (COVID-19) Spike P681R Antilichaam [7E3C5] (Delta Variant)

SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent.

43740568

P0DTC2

QHD43416

Virus

PM-9680

7E3C5

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

Anti-SARS-CoV-2 Spike P681R (Delta Variant) antibody is Protein G purified.

1 mg/mL

Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (25%)

SARS-CoV-2 Spike P681R (Delta Variant) antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

SARS-CoV-2 Spike P681R (Delta Variant) antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG2

It can only detect SARS-CoV-2 Delta Variant Spike S1 protein and does not cross-react with the spike protein of other variants.

S

Surface glycoprotein

Severe acute respiratory syndrome coronavirus 2

Zhang et al. JAMA 2021, 325 (13) : 1324-26.

Reardon. Nature 2021.

Delphine. Nature 2021, 596 (7871) : 276-280.

Anti-SARS-CoV-2 Spike P681R (Delta Variant) antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein, Delta variant

ELISA, IHC-P

1791269090

Liquid